Faeth Therapeutics, Inc. (FTH)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
18. 80
-1.8
-8.7379%
$
671.02M Market Cap
- P/E Ratio
- Div Yield
595,900 Volume
- Eps
$ 20.6
Previous Close Investors:
Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faeth Therapeutics, Inc. (FTH) Statistics
Valuation metrics
Market Cap 671.02M
Enterprise value 644.71M
Trailing P/E (ttm) -0.18
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -138.33
Price/Book (mrq) 0.85
Enterprise Value/Revenue -132.9
Enterprise Value/EBITDA -3.3
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 274.07K
Average volume (90 days) 403.91K
Price summary
52-Week low 7.45
52-Week high 42.14
Beta -
50-Day moving average 31.85
200-Day moving average 25.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 17 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 40.31%
Operating margin 40.99%
Operational effectiveness
Return on assets -1.03%
Return on equity -1.93%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -0.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -34.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 33.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 19.69%
Book value per share (mrq) 30.65
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
